Encompass Health (AMEX:EHC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage currently has a $80.00 target price on the stock. Zacks Investment Research‘s target price suggests a potential upside of 38.72% from the stock’s current price.

According to Zacks, “Encompass Health Corporation provides inpatient rehabilitation hospitals and home-based care services. It offers facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. Encompass Health Corporation, formerly known as HealthSouth Corporation, is headquartered in Birmingham, Alabama. “

A number of other research firms have also commented on EHC. UBS Group began coverage on shares of Encompass Health in a research note on Thursday. They issued a “buy” rating for the company. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research note on Thursday, July 26th. Credit Suisse Group raised their price objective on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. Mizuho reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Encompass Health in a research note on Thursday, July 26th. Finally, SunTrust Banks reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Encompass Health in a research note on Friday, July 20th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $70.70.

Encompass Health stock traded down $0.42 during midday trading on Thursday, reaching $57.67. The stock had a trading volume of 620,391 shares, compared to its average volume of 618,344. Encompass Health has a twelve month low of $40.86 and a twelve month high of $59.29.

Encompass Health (AMEX:EHC) last posted its quarterly earnings data on Monday, October 29th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.12. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis.

A number of hedge funds have recently added to or reduced their stakes in EHC. Principal Financial Group Inc. purchased a new stake in Encompass Health in the 1st quarter worth approximately $76,632,000. Acadian Asset Management LLC lifted its position in Encompass Health by 165.0% in the 3rd quarter. Acadian Asset Management LLC now owns 1,842,668 shares of the company’s stock worth $143,635,000 after buying an additional 1,147,365 shares in the last quarter. Millennium Management LLC purchased a new stake in Encompass Health in the 2nd quarter worth approximately $50,226,000. Renaissance Technologies LLC lifted its position in Encompass Health by 72.3% in the 3rd quarter. Renaissance Technologies LLC now owns 1,497,500 shares of the company’s stock worth $116,730,000 after buying an additional 628,300 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its position in Encompass Health by 47.4% in the 3rd quarter. Wells Fargo & Company MN now owns 1,803,128 shares of the company’s stock worth $140,553,000 after buying an additional 579,715 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: Why is the conference call important?

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.